End Cash: The amount of cash held by the company for the given period.
Valeant Pharmaceuticals International Inc. (T.BHC) had End Cash of 1.65B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-63.05M |
|
-- |
|
-- |
|
-- |
|
2.12B |
|
-- |
|
228.89M |
|
228.89M |
|
-98.68M |
|
-98.68M |
|
-98.68M |
|
-98.68M |
|
2.12B |
|
3.93B |
|
368.00M |
|
368.00M |
|
-0.17 |
|
-0.17 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
36.35B |
|
-- |
|
-- |
|
-- |
|
36.79B |
|
-441.33M |
|
-23.25B |
|
-441.33M |
|
367.84M |
|
| Cash Flow Statement Financials | |
2.19B |
|
-622.25M |
|
-1.19B |
|
1.32B |
|
|
End Cash |
1.65B |
327.57M |
|
205.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
1.02 |
|
-67.13 |
|
71.10% |
|
16.06% |
|
16.06% |
|
29.80% |
|
1.74% |
|
-0.48% |
|
1.73B |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
1.74 |
|
4.50 |
|
81.15 |
|
22.36% |
|
0.42% |
|
-0.27% |
|
-0.39% |
|
-1.20 |
|
4.69 |
|
5.95 |
|